These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6110283)

  • 21. Ergogenic risks elevate health risks in young athletes.
    Giesemer BA
    Pediatr Ann; 2003 Nov; 32(11):733-7. PubMed ID: 22111154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of drugs to improve athletic performance].
    Kuipers H; Hartgens F
    Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Banned performance enhancing ergogenic aids in children and adolescent athletes].
    Nemet D; Eliakim A
    Harefuah; 2007 Oct; 146(10):794-9, 812. PubMed ID: 17990397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Doping: effectiveness, consequences, prevention].
    Guezennec CY
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs in the Olympics.
    Med Lett Drugs Ther; 1984 Jul; 26(665):65-6. PubMed ID: 6146092
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacoepidemiology of the drugs used in sports as doping agents.
    Benzi G
    Pharmacol Res; 1994; 29(1):13-26. PubMed ID: 7911238
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance Use and Its Impact on Athlete Health and Performance.
    Stull T; Morse E; McDuff DR
    Psychiatr Clin North Am; 2021 Sep; 44(3):405-417. PubMed ID: 34372997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.
    Bird SR; Goebel C; Burke LM; Greaves RF
    Ann Clin Biochem; 2016 Mar; 53(Pt 2):196-221. PubMed ID: 26384361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ephedrine and other stimulants as ergogenic aids.
    Bohn AM; Khodaee M; Schwenk TL
    Curr Sports Med Rep; 2003 Aug; 2(4):220-5. PubMed ID: 12834578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system stimulants and sport practice.
    Avois L; Robinson N; Saudan C; Baume N; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i16-20. PubMed ID: 16799095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High school athletes and the use of ergogenic aid.
    Krowchuk DP; Anglin TM; Goodfellow DB; Stancin T; Williams P; Zimet GD
    Am J Dis Child; 1989 Apr; 143(4):486-9. PubMed ID: 2929532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine.
    Thiblin I; Mobini-Far H; Frisk M
    Forensic Sci Int; 2009 Jan; 184(1-3):e7-11. PubMed ID: 19110387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Many "doping pitfalls" in spite of safe measurement methods].
    Nystrand A
    Lakartidningen; 1996 Jul; 93(28-29):2570-6. PubMed ID: 8766754
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular toxicities of performance-enhancing substances in sports.
    Dhar R; Stout CW; Link MS; Homoud MK; Weinstock J; Estes NA
    Mayo Clin Proc; 2005 Oct; 80(10):1307-15. PubMed ID: 16212144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs and the adolescent athlete.
    Dyment PG
    Pediatr Ann; 1984 Aug; 13(8):602-4. PubMed ID: 6483496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sports and doping].
    Yoshida T
    Chudoku Kenkyu; 2003 Jul; 16(3):299-305. PubMed ID: 14582352
    [No Abstract]   [Full Text] [Related]  

  • 38. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Doping in adolescence].
    Kamber M; Mullis PE
    Ther Umsch; 2007 Feb; 64(2):83-9. PubMed ID: 17245674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Doping and sports].
    Lippi G; Guidi G
    Minerva Med; 1999 Sep; 90(9):345-57. PubMed ID: 10719440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.